These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8102742)

  • 1. Vancomycin-resistant enterococci.
    Wilcox MH; Spencer RC; Weeks GR
    Lancet; 1993 Sep; 342(8871):615-6. PubMed ID: 8102742
    [No Abstract]   [Full Text] [Related]  

  • 2. Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci.
    van Den Braak N; Goessens W; van Belkum A; Verbrugh HA; Endtz HP
    J Clin Microbiol; 2001 Jan; 39(1):351-3. PubMed ID: 11136798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Status and drug resistance surveillance of enterococcus infection in patients with severe hepatitis].
    Wang XD; Jiang KQ; Zhu BH; Jin RJ; Zheng B; Chen YP
    Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):375-7. PubMed ID: 16732916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin-resistant enterococci.
    Uttley AH; Woodford N; Johnson AP; Cookson B; George RC
    Lancet; 1993 Sep; 342(8871):615; author reply 616. PubMed ID: 8102741
    [No Abstract]   [Full Text] [Related]  

  • 5. VRE--a more immediate threat than Ebola.
    Barlow JF
    S D J Med; 1995 Jul; 48(7):207-8. PubMed ID: 7660100
    [No Abstract]   [Full Text] [Related]  

  • 6. From the Centers for Disease Control and Prevention. Assessment of testing for and completeness of reporting of vancomycin-resistant enterococci--Connecticut, 1994.
    JAMA; 1996 May; 275(18):1397. PubMed ID: 8618356
    [No Abstract]   [Full Text] [Related]  

  • 7. [Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
    Klare I; Witte W
    Wien Klin Wochenschr; 1997 May; 109(9):293-300. PubMed ID: 9265387
    [No Abstract]   [Full Text] [Related]  

  • 8. [Infections of vancomycin resistant enterococci (VRE) and Staphylococcus aureus (VRSA)].
    Kuwahara K; Hanaki H; Hiramatsu K
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):182-5. PubMed ID: 10088368
    [No Abstract]   [Full Text] [Related]  

  • 9. Transmission of vancomycin-resistant enterococcus among family members: a case study.
    Neuman K; Cox D; Bullough K
    J Community Health Nurs; 1998; 15(1):9-20. PubMed ID: 9519596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin-resistant enterococci: pervasive and persistent pathogens.
    Boyce JM
    Infect Control Hosp Epidemiol; 1995 Dec; 16(12):676-9. PubMed ID: 8683084
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bacteremia caused by Enterococcus gallinarum with a high level of glycopeptide resistance: 1st documented cases in Argentina].
    Togneri A; Lopardo H; Corso A
    Rev Argent Microbiol; 2003; 35(2):96-9. PubMed ID: 12920991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-resistant enterococci in hemodialysis patients is related to intravenous vancomycin use.
    Fishbane S; Cunha BA; Mittal SK; Ruggian J; Shea K; Schoch PE
    Infect Control Hosp Epidemiol; 1999 Jul; 20(7):461-2. PubMed ID: 10432156
    [No Abstract]   [Full Text] [Related]  

  • 14. Selection of a teicoplanin-resistant Enterococcus faecium mutant during an outbreak caused by vancomycin-resistant enterococci with the vanB phenotype.
    Kawalec M; Gniadkowski M; Kedzierska J; Skotnicki A; Fiett J; Hryniewicz W
    J Clin Microbiol; 2001 Dec; 39(12):4274-82. PubMed ID: 11724832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance of enterococci in Turkey.
    Kaçmaz B; Aksoy A
    Int J Antimicrob Agents; 2005 Jun; 25(6):535-8. PubMed ID: 15908184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for the management of patients colonized or infected with vancomycin-resistant enterococci.
    Bowler IC; Storr JA; Davies GJ; Crook DW
    J Hosp Infect; 1998 May; 39(1):75-7. PubMed ID: 9617689
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro susceptibility of Staphylococci and Enterococci to vancomycin and teicoplanin.
    Guzek A; Korzeniewski K; Nitsch-Osuch A; Rybicki Z; Prokop E
    Adv Exp Med Biol; 2013; 788():125-32. PubMed ID: 23835969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin-resistant enterococci: an emerging pathogen in immunosuppressed transplant recipients.
    Sastry V; Brennan PJ; Levy MM; Fishman N; Friedman AL; Naji A; Barker CF; Brayman KL
    Transplant Proc; 1995 Feb; 27(1):954-5. PubMed ID: 7879244
    [No Abstract]   [Full Text] [Related]  

  • 19. Vancomycin-resistant Enterococcus durans.
    Hall LM; Chen HY; Williams RJ
    Lancet; 1992 Oct; 340(8827):1105. PubMed ID: 1357503
    [No Abstract]   [Full Text] [Related]  

  • 20. Bloodstream infections with vancomycin-resistant enterococci.
    Montecalvo MA; Shay DK; Patel P; Tacsa L; Maloney SA; Jarvis WR; Wormser GP
    Arch Intern Med; 1996 Jul; 156(13):1458-62. PubMed ID: 8678715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.